Navigation Links
Unilens Vision Reports Record First Quarter Earnings and Royalty Income
Date:11/29/2007

First Quarter Net Income Increases 22% and Royalty Income Increases 29%

From Prior Year

LARGO, Fla., Nov. 29 /PRNewswire-FirstCall/ -- Unilens Vision Inc. (OTC Bulletin Board: UVICF) (TSX Venture Exchange: UVI), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today reported its operating results for the first quarter of FY2008.

Net sales, excluding royalty income, for the quarter ended September 30, 2007 increased to $1,673,361 compared with $1,604,776 in the quarter ending September 30, 2006, an increase of 4.3%. The increase was primarily the result of continued growth of the Company's C-Vue multifocal contact lenses, which increased approximately 11% in the current quarter, which was partially offset by sales of our replacement products lines that declined as expected.

Net Income for the quarter increased 22% to a record first quarter of $377,296, or $0.08 per diluted share, compared with $310,492, or $0.07 per diluted share in the prior-year period.

Royalty income for the quarter increased 28.6% to a record first quarter of $612,799 compared with $476,550 in the prior-year quarter. Sales of licensed products by our licensee Bausch & Lomb continue to accelerate, resulting in the record quarterly royalty.

Income before taxes for the quarter ended September 30, 2007 increased 20% to $616,501, compared with $515,183 in the prior-year quarter. After recording income tax expense of $239,205, Unilens reported net income of $377,296, or $0.08 per diluted share. In the first quarter of FY2007, the Company reported net income of $310,492, or $0.07 per diluted share, after recording income tax expense of $204,691.

"We are pleased with our first quarter operating results and are optimistic regarding the outlook for our operating results for the remainder of the current fiscal year," stated Michael J. Pecora, Chief Executive Officer of Unilens Vision Inc.,
'/>"/>

SOURCE Unilens Vision Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Unilens Names Eschenbach Optik Exclusive Worldwide Distributor of the UniVision(R) Low Vision Lens
2. Vision restoration therapy shown to improve brain activity in brain injured patients
3. Mouse vision has a rhythm all its own
4. HEI, Inc. Announces Sale of RFID Division Assets
5. QUANTEL Intends to Strengthen its Dermatology/ Aesthetics Division With the Acquisition of WaveLight Aesthetic GmbH
6. The aye-ayes have it: The preservation of color vision in a creature of the night
7. Can brain-injured, partially-blind stroke patients regain some of their lost vision?
8. HEI, Inc. Closes on Sale of RFID Division Assets
9. Elliott Extremely Dissatisfied With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company
10. Colorado Medical School Receives Provisional Accreditation
11. Poor Senior Vision Often a Window on Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... 2015 The Maricopa Community Colleges ... to the Arizona economy each year, according to a ... Economic Value of Maricopa County Community College District, summarizes ... district in fiscal year 2013-2014. , The analysis ... (EMSI), an organization that specializes in providing economic impact ...
(Date:3/5/2015)... SuperCloset has released a new video series called ... viewers everything they need to know about how to grow ... you from seed all the way through harvest, and covers ... prune Grow Like a SuperPro will help take the guesswork ... download for a special introductory price of $19.95. Or you ...
(Date:3/5/2015)... 2015 TCS Healthcare Technologies (TCS), a ... population health management arena, is pleased to announce a ... ACUITY Advanced Care™ (ACUITY) version 7.20. The session will ... the advantages of automation. , The webinar, scheduled for ... led by Jeff Frater, RN, BSN, Director of Partner ...
(Date:3/5/2015)... PA (PRWEB) March 05, 2015 ... leader in healthcare communications and education, announced today ... (AMP), the nation’s only medical conference designed ... limb ischemia and lower limb amputation due to ... growing family of innovative, evidence-based publications and CME ...
(Date:3/5/2015)... 05, 2015 Califia Farms , ... the natural products coffee drinks category[1], today unveils its ... West in Anaheim, Calif. Concentrated Cold Brew (CCB) ... Café, which democratizes the next wave of the coffee-taste ... need to become their own baristas. , Califia ...
Breaking Medicine News(10 mins):Health News:Maricopa Community Colleges Add $7.3 Billion to Local Economy Annually 2Health News:Maricopa Community Colleges Add $7.3 Billion to Local Economy Annually 3Health News:Complimentary Webinar to Explore Enhanced Version of Premier Case Management Software 2Health News:Complimentary Webinar to Explore Enhanced Version of Premier Case Management Software 3Health News:HMP Holdings Acquires The Amputation Prevention Symposium (AMP) 2Health News:HMP Holdings Acquires The Amputation Prevention Symposium (AMP) 3Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 2Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 3Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 4
... , , NAPLES, Fla., Sept. 3 ... the elderly and is projected to increase in prevalence over the ... for treatments that will prevent or reverse the now-inexorable course of ... expensive and complex, many researchers are focusing on botanical extracts whose ...
... To avoid injuries, watch backpack weight and fit, expert suggests, ... be a great help to school children, but it needs ... professionals say. , "If too heavy or worn incorrectly, ... pain," Paula Kramer, who chairs the occupational therapy department at ...
... , FRANKLIN, Mass., Sept. 3 ... ECTE), a diabetes management company developing the ... continuous glucose monitoring (tCGM) system and the Prelude(TM) SkinPrep ... that Patrick T. Mooney, M.D., Chairman and Chief Executive ...
... HARBIN, China, Sept. 3 /PRNewswire-Asia-FirstCall/ -- China Sky ... (Nasdaq: CSKI ), a,leading fully integrated pharmaceutical ... ("PRC"), today announced that the,Company has finished the required ... submitted application to the State Food and Drug Administration,(SFDA) ...
... MOUNTAIN VIEW, Calif., Sept. 3 An expanding ... the U.S. bone and joint health ingredients market. Consumers ... wellness quotient and have strong scientific backup. The rise ... need for well-researched ingredients that deliver tangible advantages. , ...
... , , CARLSBAD, Calif., ... leader in antisense therapeutics, today announced that management will present a company ... 9, 2009, at 11:30 a.m. ET at the Boston Four Seasons Hotel. ... will be available on the "Investors & Media" section of the Company,s ...
Cached Medicine News:Health News:HerbalScience Research Demonstrates that Optimized Turmeric Extract Inhibits Amyloid-Beta Accumulation, a Hallmark of Alzheimer's Disease 2Health News:HerbalScience Research Demonstrates that Optimized Turmeric Extract Inhibits Amyloid-Beta Accumulation, a Hallmark of Alzheimer's Disease 3Health News:Take the Load Off Your Child's Back 2Health News:Echo Therapeutics to Present at Rodman & Renshaw 2009 Annual Global Investment Conference 2Health News:China Sky One Medical, Inc. Submits Application to Perform Clinical Trials for Two New Eye Drugs to SFDA 2Health News:China Sky One Medical, Inc. Submits Application to Perform Clinical Trials for Two New Eye Drugs to SFDA 3Health News:Aging Population, Heightened Consumer Awareness Propel U.S. Bone and Joint Health Ingredients, Says Frost & Sullivan 2Health News:Aging Population, Heightened Consumer Awareness Propel U.S. Bone and Joint Health Ingredients, Says Frost & Sullivan 3Health News:Aging Population, Heightened Consumer Awareness Propel U.S. Bone and Joint Health Ingredients, Says Frost & Sullivan 4Health News:Isis Pharmaceuticals to Present at Thomas Weisel Partners' Healthcare Conference 2009 2
(Date:3/5/2015)... , March 5, 2015 ... pressphoto agency ( http://www.epa.eu ) - ... lancio della nuova generazione di OASIS* all,ECR 2015. Si ... ad alto campo da 1.2 T che migliora la ... nuovo traguardo nell,attenzione al comfort del paziente. Le nuove ...
(Date:3/5/2015)... DUBLIN and HAMPTON, N.J. ... (NYSE: MNK ), a leading global ... care company, announced today that they have entered into ... will acquire Ikaria, Inc. from a Madison Dearborn ... $2.3 billion. Subject to customary closing ...
(Date:3/5/2015)...  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a leading ... announced today that Atlanta -based Shepherd ... spinal cord injury and brain injury, has commenced enrollment ... progenitor cells) in newly injured patients with sensory and ... The Phase 1/2a trial follows the successful completion ...
Breaking Medicine Technology:Hitachi Medical Systems Europe lancia la nuova generazione di OASIS*: Il sistema di RM aperta ad alto campo da 1.2 T. Ancora più valore al paziente 2Hitachi Medical Systems Europe lancia la nuova generazione di OASIS*: Il sistema di RM aperta ad alto campo da 1.2 T. Ancora più valore al paziente 3Hitachi Medical Systems Europe lancia la nuova generazione di OASIS*: Il sistema di RM aperta ad alto campo da 1.2 T. Ancora più valore al paziente 4Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 2Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 4Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 5Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 6Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 7Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 8Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 9Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 4
Used in conjunction with the E5381 600 Circling Band (40 style). Indications: Narrow scleral bed. Overall length: 100 mm, 3.9 inches....
...
...
...
Medicine Products: